According to a Washington Post report, this 2020 flu season more than 173 million Americans have undergone vaccination against the flu.  What would it be like if all 325 million Americans underwent vaccination against the newly mutated COVID-19 coronavirus, now being developed by a number of biotech companies?

Something good is coming out of this epidemic

The good thing that is coming out of a well-publicized infectious disease epidemic for which there is no vaccine, is the public can finally see what happens when no vaccine is available.  This analysis reveals most healthy people (non-smokers, non-diabetic, non-obese) have an onboard immune system that produces antibodies naturally without problematic provocation from pathogenic bacteria and viruses housed in a syringe and infused via needle injection.

Frightening error

An egregious and flagrant error in the news media that is frightening the public is to state the death rate from COVID-19 coronavirus is 2.3% to 3.4%.  The public thinks this is 2-4 people out of 100.

In reality, the number infected as of March 9, 2020 in China is 80,739 infected individuals out of a population of 58 million in Hubei Province (Wuhan is epicenter), for an infection rate of 0.0014 or less than 1% (just over 1/10th of one percent).  

Then among these infected cases, the number of deaths is 3120 (as of March 9, 2020) which is 5 in 100,000.  Due to the fact Americans have chlorinated water, food fortification and availability of dietary supplements that boost immunity, the same death rate as reported in China is not anticipated in the U.S.

Universal vaccination of both healthy and younger American adults would be a blatantly untargeted way to save lives.  The greatest number of deaths due to the flu or any strain of coronavirus occurs among senior adults.  If it were possible to eliminate deaths due to infectious diseases such as the flu and coronavirus among senior Americans, it would be almost needless to vaccinate in order to save lives, though there may be some rationale to vaccinate in order to reduce morbidity and hospitalization.

Imagine this

Utilizing data gleaned from current reports involving the COVID-19 coronavirus and prior flu vaccine studies, the safety and effectiveness of any future COVID-19 flu vaccine can be predicted.

The following is a worse-case scenario.

In a more targeted fashion, let's vaccinate every senior American age 60 and above against coronavirus.

Let's estimate a new coronavirus vaccine would be 100% effective.  (Current flu vaccines are only ~50% effective.)

To predict the percent of vaccinated individuals who might develop serious side effects, let's use a study of senior adults in the U.S. (a well-fed population) that received standard and high-dose inactivated trivalent (three strains) flu vaccine for comparison, where severe side effects resulting in hospitalization were reported for 0.6% to 1.3% of vaccinated subjects.

Let's presume everyone will be infected with the coronavirus and be a candidate for the vaccine (that is not true, and if your immune system is up to par, if infected you may only experience a mild fever or no symptoms whatsoever, then develop natural antibodies, as millions of Americans are now doing).